InterventionsAnimalsMice10 days

Raloxifene and progesterone neuroprotection in a female mouse model of Parkinson's disease

Figure 1. Effects of a chronic treatment with raloxifene and progesterone on uterine weight of unlesioned saline-treated and MPTP-lesioned ovariectomized female mice.
Open the figure at full size
Figure 1. Effects of a chronic treatment with raloxifene and progesterone on uterine weight of unlesioned saline-treated and MPTP-lesioned ovariectomized female mice.Effects of a chronic treatment with raloxifene and progesterone on uterine weight of unlesioned saline-treated and MPTP-lesioned ovariectomized female mice.André et al.

Frontiers in Neuroscience

The paper

André MM, Morissette M, Bourque M et al.

Frontiers in Neuroscience · 9 Sep 2026

doi.org/10.3389/fnins.2026.1870069PubMed 42780212

More on Parkinson's disease